Searchable abstracts of presentations at key conferences in endocrinology

ea0023oc1.5 | Oral Communications 1 | BSPED2009

The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor obscurin-like 1

Hanson D , Murray P G , Sud A , Temtamy S A , Aglan M , Superti-Furga A , Holder S E , Urquhart J , Hilton E , Manson F D C , Scambler P , Black G C M , Clayton P E

3-M syndrome is an autosomal recessive primordial growth disorder characterized by pre- and post-natal growth restriction, facial dysmorphism and radiological abnormalities. Mutations in the gene CUL7 have been previously shown to cause 3-M syndrome. CUL7 is a member of the cullin family of E3 ubiquitin ligases involved in targeted protein degradation.We identified a large cohort of 3-M syndrome patients who did not carry CUL7 mutations but...

ea0073aep842 | Late Breaking | ECE2021

The first comprehensive study of the clinical response of a cohort of acromegalic patients with somatostatin responsive headache

Sonia Kaniuka-Jakubowska , J Levy Miles , Pal Aparna , Abeyaratne Dayakshi , Drake William , Kyriakakis Nikolaos , D Murray Robert , M Orme Steve , Gohil Shailesh , Brook Antonia , Leese Graham , Márta Korbonits , Wass John

It is known that acromegaly may be associated with headache as a significant co-morbidity. Amongst all acromegaly headache patients, there is a unique group with specific types of severe headache that fail to improve despite acromegaly therapy and are resistant to conventional analgesics, however, immediately respond to subcutaneous short-acting (SA) somatostatin analogue (SSA) treatment. We have surveyed 8 tertiary specialist UK centres and identified 18 patients (6 females) ...

ea0094op1.3 | Neuroendocrinology and Pituitary | SFEBES2023

Biochemical control does not improve functional impairment in people with acromegaly

Z Safdar Nawaz , Heague Megan , Hebden Sophie , Lynch Julie , Mclaren David , Tresoldi Alberto , Lithgow Kirstie , Urwyler Sandrine , Akbar Shahzad , McLoughlin Katie , Kearney Tara , Drake William M. , Sathyapalan Thozhukat , Orme Steve , E Higham Claire , Karavitaki Niki , Kyriakakis Nikolaos , Murray Robert

Acromegaly, a chronic disorder of excessive growth hormone secretion, leads to functional limitation and impaired mobility most commonly due to arthropathy. Patients with biochemically controlled acromegaly have reported persistent impairment in prior studies. We aimed to compare the functional differences in patients with biochemically controlled acromegaly to those with uncontrolled disease by means of validated questionnaires. Between March 2017 and May 2022, patients over ...

ea0094p233 | Neuroendocrinology and Pituitary | SFEBES2023

Characterisation of the Impact of Joint Pain on Patients with Acromegaly

Hebden Sophie , Safdar Nawaz , Heague Megan , Lynch Julie , Mclaren David , Tresoldi Alberto , Lithgow Kirstie , Urwyler Sandrine , Akbar Shahzad , McLoughlin Katie , Kearney Tara , M Drake William , Sathyapalan Thozhukat , Orme Steve , E Higham Claire , Karavitaki Niki , Kyriakakis Nikolaos , Murray Robert

Acromegaly is caused by excessive growth hormone (GH) and insulin-like growth factor (IGF-1) secretion. Arthropathy is a leading cause of morbidity and impaired quality of life in acromegalic patients, often persisting despite therapeutic interventions and biochemical control. This cross-sectional study aimed to characterise the extent and impact of arthropathy in terms of pain and functional impairment. Validated questionnaires, including DASH (Disabilities of the Arm, Should...

ea0094oc3.5 | Neuroendocrinology and Pituitary | SFEBES2023

The effects of biochemical control and Arthropathy on Quality of Life in patients with Acromegaly: a cross-sectional study

Megan Heague , Nawaz Safdar , Sophie Hebden , Julie Lynch , David McLaren , Alberto Tresoldi , Kirstie Lithgow , Sandrine Urwyler , Shahzad Akbar , Katie McLoughlin , Tara Kearney , William M. Drake , Thozhukat Sathyapalan , Steve Orme , Claire E. Higham , Niki Karavitaki , Nikolaos Kyriakakis , Robert D. Murray

One of the most prevalent clinical manifestations of acromegaly is arthropathy which persists despite adequate symptom and biochemical control, and contributes to impaired quality of life. Patients with acromegaly have high psychiatry morbidity and increased prevalence of depression and poor psychological wellbeing. In a large cohort we aim to determine the effects of joint disease and disease control on quality of life in acromegaly. Eighty-five patients (45 women; median age...

ea0090ep506 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Celiac disease in adult patients with type 1 diabetes: screening and clinical and paraclinical profile

Ben Amor Nadia , Karboul Youssef , Mahjoub Faten , Olfa Berriche , Zemni Zeineb , Ouderni Imen , Ben Othman Rym , Mizouri Ramla , Lahmar Ines , Gamoudi Amel , Henda Jamoussi

Aims: Screening for celiac disease in adult type 1 diabetics and studying its clinical and paraclinical profile.Patients and methods: Cross-sectional descriptive study conducted among 150 adult type 1 diabetic patients followed in Department A of the National Institute of Nutrition of Tunis. All patients underwent serological screening for celiac disease.Results: The prevalence of histologically confirmed celiac disease was 3.33% w...

ea0077oc1.5 | Reproductive and Neuroendocrinology | SFEBES2021

Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients

Hamblin Ross , Vardon Ashley , Akpalu Josephine , Tampourlou Metaxia , Spiliotis Ioannis , Sbardella Emilia , Lynch Julie , Shankaran Vani , Mavilakandy Akash , Gagliardi Irene , Meade Sara , Hobbs Claire , Levy Miles J , Cameron Alison , Grossman Ashley , Rosaria Ambrosio Maria , Chiara Zatelli Maria , Reddy Narendra , Bradley Karin , Murray Robert D , Pal Aparna , Karavitaki Niki

Background: Current conclusions on risk of second brain tumour following radiotherapy for pituitary adenoma or craniopharyngioma are challenged methodologically by small patient sample size, selection biases or lack of appropriate controls.Objective: To ascertain whether radiotherapy for pituitary adenoma or craniopharyngioma is associated with increased second brain tumour risk, through use of appropriate methodology.Design: Multi...

ea0081yi7 | Young Investigator Awards | ECE2022

Radiotherapy for adults with pituitary adenoma or craniopharyngioma is associated with increased risk of second brain tumour : A multi-centre study of 3,613 patients with long-term imaging surveillance

Hamblin Ross , Vardon Ashley , Akpalu Josephine , Tampourlou Metaxia , Spiliotis Ioannis , Sbardella Emilia , Lynch Julie , Shankaran Vani , Mavilakandy Akash , Gagliardi Irene , Meade Sara , Hobbs Claire , Cameron Alison , Levy Miles J , Ayuk John , Grossman Ashley , Ambrosio Maria Rosaria , Zatelli Maria Chiara , Reddy Narendra , Bradley Karin , Murray Robert , Pal Aparna , Karavitaki Niki

Background: The risk of a second brain tumour following radiotherapy for pituitary adenoma or craniopharyngioma in adults is currently unclear. Studies are methodologically limited by small patient sample size, few case events, selection biases or the use of inappropriate controls.Objective: To ascertain whether radiotherapy delivered to adults with pituitary adenoma or craniopharyngioma is associated with an increased second brain tumour risk using appr...

ea0090p288 | Adrenal and Cardiovascular Endocrinology | ECE2023

Symptoms and Steroid Dose Adjustments Associated with the SARS-CoV-2 Vaccine in Patients with Adrenal Insufficiency

McLaren David , Crowe Grace , Cassidy Christine , Rasool Irum , elsabbagh mohamed , Eyadeh Ahmad , Poe Poe Han Htwe Nang , Gerrard Melinda , Ward Emma , Kassim Saifuddin , Abbas Afroze , Al-Qaissi Ahmed , M Orme Steve , Seejore Khyatisha , Kyriakakis Nikolaos , Maguire Deirdre , Lynch Julie , D Murray Robert

Background: Following vaccination for SARS-CoV-2 a significant proportion of individuals experience moderate to severe symptoms. In patients with adrenal insufficiency (AI) this has been reported to translate in to need for increased glucocorticoids and incipient or frank adrenal crises. We assessed occurrence of symptoms, need for glucocorticoid dose adjustment and crises in a large cohort of patients with AI following vaccination for SARS-CoV-2.Methods...

ea0063oc3.2 | Cushing's and acromegaly | ECE2019

Outcomes after primary treatment for Nelson’s syndrome: a study from 13 UK centres

Fountas Athanasios , Lim Eugenie , Drake William M , Polson Andrew , Gurnell Mark , Martin Niamh M , Seejore Khyatisha , Murray Robert D , MacFarlane James , Ahluwalia Rupa , Swords Francesca , Ashraf Muhammad , Pal Aparna , Chong Zhuomin , Freel Marie , Balafshan Tala , Purewal Tejpal S , Speak Rowena G , Newell-Price John , Higham Claire , Hussein Ziad , Baldeweg Stephanie E , Dales Jolyon , Reddy Narendra , Levy Miles , Karavitaki Niki

Nelson’s syndrome (NS) is a potentially severe complication following bilateral adrenalectomy for Cushing’s disease (CD). Series assessing outcomes of treatments for NS are limited by small sample size, often short follow-up and variability of success criteria. We performed a UK multi-centre study aiming to review outcomes of primary treatment for NS. Clinical, laboratory, imaging data were collected. Kaplan-Meier method, log-rank test, Cox regression analysis were u...